TARA Biosystems Partners with Scipher Medicine®

TARA Biosystems Partners with Scipher Medicine®

Scipher to use proprietary patient molecular data analyzed by its SpectraTM platform to identify novel drug targets TARA Biosystems to progress selected targets in its BiowireTM II drug discovery platform forcardiac laminopathies. Partnership set to reduce target...
Can a Blood-Based Test Predict TNFi Nonresponse in RA?

Can a Blood-Based Test Predict TNFi Nonresponse in RA?

Richard Mark Kirkner via Medscape A blood test that uses a patient’s unique genetic signature has shown some ability to predict nonresponse to tumor necrosis factor inhibitors as treatment for rheumatoid arthritis, an observational clinical study has found, but...